Gene · 3713
Papers3,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 3,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Natural and Synthetic Bioactives for Skin Health, Disease and Management. | Nutrients | 2021 | 34959935 | PubTator, text mining | PubMed |
| The role of cancer stromal fibroblasts in mediating the effects of tobacco-induced cancer cell growth. | Cancer Cell Int | 2021 | 34953503 | PubTator, text mining | PubMed |
| Preparation, Characterization and Evaluation of the Anti-Inflammatory Activity of Epichlorohydrin-β-Cyclodextrin/Curcumin Binary Systems Embedded in a Pluronic®/Hyaluronate Hydrogel. | Int J Mol Sci | 2021 | 34948364 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Eosinophilic Esophagitis. | Int J Mol Sci | 2021 | 34947981 | PubTator, text mining | PubMed |
| Topical Application of Galgeunhwanggeumhwangryeon-Tang Recovers Skin-Lipid Barrier and Ameliorates Inflammation via Filaggrin-Thymic Stromal Lymphopoietin-Interleukin 4 Pathway. | Medicina (Kaunas) | 2021 | 34946332 | PubTator, text mining | PubMed |
| Role of Aryl Hydrocarbon Receptor Activation in Inflammatory Chronic Skin Diseases. | Cells | 2021 | 34944067 | PubTator, text mining | PubMed |
| Barrier Impairment and Type 2 Inflammation in Allergic Diseases: The Pediatric Perspective. | Children (Basel) | 2021 | 34943362 | PubTator, text mining | PubMed |
| Flavonoids Present in Propolis in the Battle against Photoaging and Psoriasis. | Antioxidants (Basel) | 2021 | 34943117 | PubTator, text mining | PubMed |
| Deferoxamine Treatment Improves Antioxidant Cosmeceutical Formulation Protection against Cutaneous Diesel Engine Exhaust Exposure. | Antioxidants (Basel) | 2021 | 34943031 | PubTator, text mining | PubMed |
| Eisenia bicyclis Extract Repairs UVB-Induced Skin Photoaging In Vitro and In Vivo: Photoprotective Effects. | Mar Drugs | 2021 | 34940692 | PubTator, text mining | PubMed |
| Generation of a lung squamous cell carcinoma three-dimensional culture model with keratinizing structures. | Sci Rep | 2021 | 34934075 | PubTator, text mining | PubMed |
| Khat (Catha Edulis Forsk) induced apoptosis and cytotoxicity in cultured cells: A scoping review. | Heliyon | 2021 | 34926848 | PubTator, text mining | PubMed |
| TP53 Mutation Infers a Poor Prognosis and Is Correlated to Immunocytes Infiltration in Breast Cancer. | Front Cell Dev Biol | 2021 | 34917611 | PubTator, text mining | PubMed |
| Mobilizing Endogenous Repair Through Understanding Immune Reaction With Biomaterials. | Front Bioeng Biotechnol | 2021 | 34917594 | PubTator, text mining | PubMed |
| Systems biology analysis of human genomes points to key pathways conferring spina bifida risk. | Proc Natl Acad Sci U S A | 2021 | 34916285 | PubTator, text mining | PubMed |
| Deletion of TNFAIP6 Gene in Human Keratinocytes Demonstrates a Role for TSG-6 to Retain Hyaluronan Inside Epidermis. | JID Innov | 2021 | 34909750 | PubTator, text mining | PubMed |
| Characterization of Human Keratinocyte Cell Lines for Barrier Studies. | JID Innov | 2021 | 34909717 | PubTator, text mining | PubMed |
Unlocking the Mechanisms of Cutaneous Adverse Drug Reactions: Activation of the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway by EGFR Inhibitors Triggers Keratinocyte Differentiation and Polarization of Epidermal Immune Responses. | JID Innov | 2021 | 34909713 | PubTator, text mining | PubMed |
| Alterations of Chromatin Regulators in the Pathogenesis of Urinary Bladder Urothelial Carcinoma. | Cancers (Basel) | 2021 | 34885146 | PubTator, text mining | PubMed |
| Development of an Aged Full-Thickness Skin Model Using Flexible Skin-on-a-Chip Subjected to Mechanical Stimulus Reflecting the Circadian Rhythm. | Int J Mol Sci | 2021 | 34884594 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3713/papers?page=38